Sustainable inhaler treatment: a case study on balancing patient interests with environmental sustainability: mainstreaming ethics in health and climate action
Overview
Part of the WHO series "Mainstreaming ethics in health and climate action", this case study explores how health-care providers can reduce the environmental impact of inhaler treatment while protecting patients’ interests. Focusing on an initiative undertaken by SingHealth in Singapore, it examines the promotion of lower-emission, propellant-free inhalers and measures to reduce medication waste. It considers the ethical challenges involved in balancing environmental benefits with clinical efficacy and safety, patient autonomy, treatment preferences, trust, equitable access and the financial and practical burdens of sustainable prescribing.
The case study emphasizes individualized prescribing, informed and non-coercive patient engagement, and continued access to conventional inhalers where clinically necessary. It highlights the importance of institutional support, shared responsibility among health-care providers, institutions and patients, and measures to address systemic barriers to sustainable treatment. The lessons learned underscore the need to integrate environmental considerations into respiratory care without compromising patient outcomes, professional responsibilities or equity.